Shengdi Chen, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, China
solidcolours / Getty Images / iS
noipornpan / Getty Images / iStock
Editor-in-Chief
Journal news
For new submissions from 1st January 2019, authors will need to pay an article publishing charge (APC) of £1690.00/$2400.00/€2040.00 for each article submitted and accepted for publication in the journal.
Aims and Scope
Translational Neurodegeneration is an open access, peer-reviewed journal that covers research, therapeutics and education for all aspects of neurodegenerative diseases. By offering a high-visibility forum for new insights and discussions, Translational Neurodegeneration creates a novel interface between the fields of basic, translational, and clinical research. It includes Parkinson's disease and movement disorders, Alzheimer's disease and other dementias, motor neuron disease and other neurodegenerative diseases.
Advertisement
Affiliated with
Annual Journal Metrics
-
Speed
60 days to first decision for reviewed manuscripts only
35 days to first decision for all manuscripts
117 days from submission to acceptance
19 days from acceptance to publication
Citation Impact5.534 - 2-year Impact Factor
1.479 - Source Normalized Impact per Paper (SNIP)
2.346 - SCImago Journal Rank (SJR)Usage
199,998 downloads
106 Altmetric mentions
Advertisement
